-
. While candidates in all areas will be considered, priority will be given to the following areas: Embodied AI Software, Systems, and Security AI and Life Sciences Socially Responsive AI Appointments will
-
revolutionize the healthcare penetration testing marketplace by shifting the focus from compliance-based checklists to understanding how gracefully a hospital system fails and recovers under attack. The platforms
-
, or health-related field by the appointment start date. A record of outstanding research during the Ph.D., as evidenced by publications, grants, software outputs, and other scholarly measures of impact
-
and engineering before the appointment start date A record of outstanding research during the Ph.D., as evidenced by publications, grants, software outputs, and other scholarly measures of impact
-
examine how individual differences in these processes confer risk or resilience to mental health problems. As part of the Center for Cognitive and Brain Health, there is ample opportunity for collaboration
-
. About Eidos and BridgeBio Pharma Inc. BridgeBio Pharma, Inc. (BridgeBio/BBIO) is a biopharmaceutical company founded to discover, create, test and deliver transformative medicines to treat patients who